Citius Oncology Inc (CTOR) concluded trading on Wednesday at a closing price of $1.57, with 16.13 million shares of worth about $25.32 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 42.73% during that period and on July 16, 2025 the price saw a gain of about 1.95%. Currently the company’s common shares owned by public are about 71.55M shares, out of which, 3.52M shares are available for trading.
Stock saw a price change of -63.82% in past 5 days and over the past one month there was a price change of 6.80%. Year-to-date (YTD), CTOR shares are showing a performance of -86.18% which increased to 36.52% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.55 but also hit the highest price of $49.00 during that period. The average intraday trading volume for Citius Oncology Inc shares is 1.20 million. The stock is currently trading -52.45% below its 20-day simple moving average (SMA20), while that difference is down -18.15% for SMA50 and it goes to 24.13% higher than SMA200.
Citius Oncology Inc (NASDAQ: CTOR) currently have 71.55M outstanding shares and institutions hold larger chunk of about 0.15% of that.
The stock has a current market capitalization of $112.34M and its 3Y-monthly beta is at 3.26. It has posted earnings per share of -$0.19 in the same period. It has Quick Ratio of 0.05 while making debt-to-equity ratio of 0.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CTOR, volatility over the week remained 34.78% while standing at 31.41% over the month.
Stock’s fiscal year EPS is expected to drop by -54.84% while it is estimated to increase by 110.42% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on November 27, 2024 offering a Buy rating for the stock and assigned a target price of $3 to it.
